Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch
Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern.
Pill Connect, formerly known as Elucid mHealth, has secured £510,000 funding to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US and continue through to commercial launch.
Pill Connect was developed to prompt patients to take their medications on time and to send a report back to the doctor to advise them of their patients' adherence record. The prompt comes from an app on their mobile phone which when acknowledged dispenses a pill or capsule from the bottle through the dispensing cap. Should the patient not wish to take their medication due to illness or an adverse reaction they can respond through the app.
In addition to providing a detailed adherence record, the Pill Connect system allows for an immediate intervention by an automated notification or phone call should the app not be activated.
This is particularly important in clinical trials where poor adherence can compromise the validity of the trial. It is well known that compliance rapidly declines over time and in longer studies, especially lasting longer than 9 months, adherence drops off. The Pill Connect system allows monitors to not only know when that happens but to have the opportunity to intervene and talk to the person in real time, to assess what can be done to help them become more compliant.
The monitor has access to a complete dashboard covering the whole trial so that everyone involved can be advised in real time of the rate of compliance or issues which affect adherence.
The Pill Connect system has already undergone several successful placebo trials which have proven the robustness of the system, the ability to influence better compliance in real time and frictionless patient acceptance.
The system continues to be trialled by both clinical research organizations and major pharma companies who have found that the ability of the system to interact in real time differentiates it from many other products in development.
The Pill Connect dispenser mechanism and electronics are designed to fit as a cap onto a standard pill bottle. The capacity of the pill bottle will depend upon the pill size but will have a minimum of 30 pills. The dispensing mechanism can be adjusted to handle pills or capsules of different sizes.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance